Scharff P - Search Results

1

Effect of C₆₀ fullerene nanoparticles on the diet-induced obesity in rats.

Halenova T, Raksha N, Vovk T, Savchuk O, Ostapchenko L, Prylutskyy Y, Kyzyma O, Ritter U, Scharff P. Halenova T, et al. Among authors: scharff p. Int J Obes (Lond). 2018 Dec;42(12):1987-1998. doi: 10.1038/s41366-018-0016-2. Epub 2018 Jan 30. Int J Obes (Lond). 2018. PMID: 30401827

2

Effect of the visible light irradiation of fullerene-containing composites on the ROS generation and the viability of tumor cells.

Prylutska SV, Burlaka AP, Matyshevska OP, Golub AA, Potebnya GP, Prylutskyy YI, Ritter U, Scharff P. Prylutska SV, et al. Among authors: scharff p. Exp Oncol. 2006 Jun;28(2):160-2. Exp Oncol. 2006. PMID: 16837910

3

Monte Carlo simulation of intercalated carbon nanotubes.

Mykhailenko O, Matsui D, Prylutskyy Y, Le Normand F, Eklund P, Scharff P. Mykhailenko O, et al. Among authors: scharff p. J Mol Model. 2007 Jan;13(1):283-7. doi: 10.1007/s00894-006-0129-8. Epub 2006 Oct 11. J Mol Model. 2007. PMID: 17033783

4

Therapeutic reactive oxygen generation.

Scharff P, Ritter U, Matyshevska OP, Prylutska SV, Grynyuk II, Golub AA, Prylutskyy YI, Burlaka AP. Scharff P, et al. Tumori. 2008 Mar-Apr;94(2):278-83. doi: 10.1177/030089160809400221. Tumori. 2008. PMID: 18564617

5

Low-temperature 1H-NMR spectroscopic study of doxorubicin influence on the hydrated properties of nanosilica modified by DNA.

Turov VV, Chehun VF, Barvinchenko VN, Krupskaya TV, Prylutskyy YI, Scharff P, Ritter U. Turov VV, et al. Among authors: scharff p. J Mater Sci Mater Med. 2011 Mar;22(3):525-32. doi: 10.1007/s10856-011-4237-3. Epub 2011 Feb 2. J Mater Sci Mater Med. 2011. PMID: 21287246

6

Pristine C(60) fullerenes inhibit the rate of tumor growth and metastasis.

Prylutska SV, Burlaka AP, Prylutskyy YI, Ritter U, Scharff P. Prylutska SV, et al. Among authors: scharff p. Exp Oncol. 2011 Sep;33(3):162-4. Exp Oncol. 2011. PMID: 21956470

7

Effect of fullerene C60 on ATPase activity and superprecipitation of skeletal muscle actomyosin.

Andreichenko KS, Prylutska SV, Medynska KO, Bogutska KI, Nurishchenko NE, Prylutskyy YI, Ritter U, Scharff P. Andreichenko KS, et al. Among authors: scharff p. Ukr Biokhim Zh (1999). 2013 Mar-Apr;85(2):20-6. Ukr Biokhim Zh (1999). 2013. PMID: 23808306

8

Effect of iron-doped multi-walled carbon nanotubes on lipid model and cellular plasma membranes.

Prylutska S, Bilyy R, Schkandina T, Bychko A, Cherepanov V, Andreichenko K, Stoika R, Rybalchenko V, Prylutskyy Y, Scharff P, Ritter U. Prylutska S, et al. Among authors: scharff p. Mater Sci Eng C Mater Biol Appl. 2012 Aug 1;32(6):1486-9. doi: 10.1016/j.msec.2012.04.029. Epub 2012 Apr 24. Mater Sci Eng C Mater Biol Appl. 2012. PMID: 24364949

9

C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.

Prylutska S, Grynyuk I, Matyshevska O, Prylutskyy Y, Evstigneev M, Scharff P, Ritter U. Prylutska S, et al. Among authors: scharff p. Drugs R D. 2014 Dec;14(4):333-40. doi: 10.1007/s40268-014-0074-4. Drugs R D. 2014. PMID: 25504158 Free PMC article.

10

C60 fullerene prevents genotoxic effects of doxorubicin in human lymphocytes in vitro.

Afanasieva KS, Prylutska SV, Lozovik AV, Bogutska KI, Sivolob AV, Prylutskyy YI, Ritter U, Scharff P. Afanasieva KS, et al. Among authors: scharff p. Ukr Biochem J. 2015 Jan-Feb;87(1):91-8. Ukr Biochem J. 2015. PMID: 26036135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters